Discussion on the Mechanism of Gushen Xiezhuo Heluo Prescription in the Treatment of Diabetic Kidney Disease Based on Network Pharmacology and Molecular Docking
Objective To discuss the mechanism of Gushen Xiezhuo Heluo Prescription in the treatment of diabetic kidney disease through network pharmacology and molecular docking technology.Methods The active components of Gushen Xiezhuo Heluo Prescription and the corrsponding targets were retrieved from the TCMSP and TCMID database.DrugBank,OMIM,GeneCards and TTD database were used to retrieve the targets of diabetic kidney disease.A Venn diagram was drawn by taking the intersection of drugs and disease targets.The Cytoscape 3.9.1 software was used to map the"drug-active component-target"network.Protein-protein interaction(PPI)network was created by the STRING.GO enrichment analysis and KEGG enrichment analysis were performed on the intersecting targets using the Metascape platform.AutoDock Vina 1.1.2 software was used to perform molecular docking validation on core active components and core targets.Results In this study,164 active components were screened,corresponding to 285 targets,882 disease targets,and 116 intersection targets;GO and KEGG enrichment analysis obtained 2 821 items and 185 pathways,respectively.The molecular docking results indicated that the core components such as quercetin,luteolin,and kaempferol in Gushen Xiezhuo Heluo Prescription had good binding activity with core targets such as TNF,AKT1,IL6,and VEGFA.Conclusion This study explores the mechanism of Gushen Xiezhuo Heluo Prescription in treating diabetic nephropathy through network pharmacology and molecular docking technology.It was found that the core active components in this prescription,such as quercetin,luteolin and kaempferol,may act on core targets such as TNF,AKT1,IL6 and VEGFA through signaling pathways such as AGE-RAGE,PI3K-Akt,and MAPK signaling pathway,thereby exerting anti-inflammatory,antioxidant,anti fibrotic,hemodynamic,and regulatory effects on cell proliferation and apoptosis.